CN113908089A - Composition with effects of moisturizing and soothing skin and application thereof - Google Patents
Composition with effects of moisturizing and soothing skin and application thereof Download PDFInfo
- Publication number
- CN113908089A CN113908089A CN202111059569.1A CN202111059569A CN113908089A CN 113908089 A CN113908089 A CN 113908089A CN 202111059569 A CN202111059569 A CN 202111059569A CN 113908089 A CN113908089 A CN 113908089A
- Authority
- CN
- China
- Prior art keywords
- skin
- parts
- extract
- composition
- moisturizing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 60
- 230000003020 moisturizing effect Effects 0.000 title claims abstract description 47
- 230000000694 effects Effects 0.000 title claims abstract description 45
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 39
- 239000002537 cosmetic Substances 0.000 claims abstract description 17
- 239000000284 extract Substances 0.000 claims description 80
- BNMGUJRJUUDLHW-HCZMHFOYSA-N Madecassoside Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(C[C@@H](O)[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O BNMGUJRJUUDLHW-HCZMHFOYSA-N 0.000 claims description 23
- BNMGUJRJUUDLHW-HLUHVYOBSA-N Madecassoside Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5[C@H](O)C[C@@]34C)[C@@H]2[C@H]1C)C(=O)O[C@@H]6O[C@H](CO[C@@H]7O[C@H](CO)[C@@H](O[C@@H]8O[C@H](C)[C@H](O)[C@@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@@H](O)[C@H](O)[C@H]6O BNMGUJRJUUDLHW-HLUHVYOBSA-N 0.000 claims description 23
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 claims description 23
- 229940090813 madecassoside Drugs 0.000 claims description 23
- 239000000047 product Substances 0.000 claims description 22
- 244000042430 Rhodiola rosea Species 0.000 claims description 21
- 235000003713 Rhodiola rosea Nutrition 0.000 claims description 21
- 241000208689 Eucommia ulmoides Species 0.000 claims description 19
- 241000195493 Cryptophyta Species 0.000 claims description 12
- 206010011732 Cyst Diseases 0.000 claims description 12
- 208000031513 cyst Diseases 0.000 claims description 12
- 244000068988 Glycine max Species 0.000 claims description 10
- 235000010469 Glycine max Nutrition 0.000 claims description 10
- 241000186660 Lactobacillus Species 0.000 claims description 10
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 10
- 238000000855 fermentation Methods 0.000 claims description 10
- 230000004151 fermentation Effects 0.000 claims description 10
- 229940039696 lactobacillus Drugs 0.000 claims description 10
- 239000008267 milk Substances 0.000 claims description 10
- 210000004080 milk Anatomy 0.000 claims description 10
- 235000013336 milk Nutrition 0.000 claims description 10
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 10
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 8
- 150000005846 sugar alcohols Polymers 0.000 claims description 5
- 241001544359 Polyspora Species 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 3
- 239000000686 essence Substances 0.000 claims description 3
- 241001414751 Rhodospora Species 0.000 claims description 2
- 239000000499 gel Substances 0.000 claims description 2
- 239000006210 lotion Substances 0.000 claims 1
- 210000003205 muscle Anatomy 0.000 abstract description 12
- 208000003251 Pruritus Diseases 0.000 abstract description 10
- 230000008591 skin barrier function Effects 0.000 abstract description 10
- 208000002193 Pain Diseases 0.000 abstract description 4
- 230000036407 pain Effects 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 4
- 230000007803 itching Effects 0.000 abstract description 3
- 210000003491 skin Anatomy 0.000 description 69
- 238000012360 testing method Methods 0.000 description 32
- 230000001815 facial effect Effects 0.000 description 19
- 230000000052 comparative effect Effects 0.000 description 16
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 12
- 241000218228 Humulus Species 0.000 description 11
- 230000037307 sensitive skin Effects 0.000 description 11
- 206010015150 Erythema Diseases 0.000 description 8
- 230000008859 change Effects 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 241000208688 Eucommia Species 0.000 description 4
- 241000223252 Rhodotorula Species 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241001165494 Rhodiola Species 0.000 description 2
- 206010040844 Skin exfoliation Diseases 0.000 description 2
- 102000003566 TRPV1 Human genes 0.000 description 2
- 101150016206 Trpv1 gene Proteins 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- -1 astringent Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000035618 desquamation Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 108091005708 gustatory receptors Proteins 0.000 description 2
- 210000003630 histaminocyte Anatomy 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000007830 nerve conduction Effects 0.000 description 2
- 239000003973 paint Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- QDZOEBFLNHCSSF-PFFBOGFISA-N (2S)-2-[[(2R)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2R)-2-amino-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-N-[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]pentanediamide Chemical compound C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](N)CCCNC(N)=N)C1=CC=CC=C1 QDZOEBFLNHCSSF-PFFBOGFISA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 206010013082 Discomfort Diseases 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 241000168525 Haematococcus Species 0.000 description 1
- 244000025221 Humulus lupulus Species 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- 208000007920 Neurogenic Inflammation Diseases 0.000 description 1
- 241001466487 Phaeocystis Species 0.000 description 1
- 102100024304 Protachykinin-1 Human genes 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 101800003906 Substance P Proteins 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010047141 Vasodilatation Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
- 229960002986 dinoprostone Drugs 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000001339 gustatory effect Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 230000003040 nociceptive effect Effects 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000001044 sensory neuron Anatomy 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a composition with the effects of moisturizing and relieving skin, which comprises the following components: the composition can be applied to cosmetics, can quickly relieve red, itching and pain discomfort symptoms of sensitive muscles, consolidate skin barriers, immediately replenish and lock water for the skins, and has remarkable moisturizing and relieving effects.
Description
Technical Field
The invention relates to the technical field of cosmetics, and particularly relates to a composition with effects of moisturizing and soothing skin and application thereof.
Background
More and more people have been afflicted with sensitive muscles in recent years. Sensitive muscles are a metastable skin that exhibits an intolerant skin condition in response to environmental changes and the use of care products. Sensitive skin is easy to cause the problems of skin itch, red swelling and the like when being stimulated by external ultraviolet rays, pollen, cold air, fragrance and the like. The sensitive skin has a thin gelatinous layer, red blood streak may appear seriously, and desquamation is easy to appear. For people with obvious facial blood vessels, the cheeks are easily engorged with blood and red and swollen. Sensitive skin, because of its thin stratum corneum, has a poor water-locking capacity, and may also exhibit a tendency to dry and tight skin that is not seasonal, and that is always dry and crispy regardless of the season, and may also exhibit a tingling sensation after application of moisturizing skin care products.
The etiology of the sensitive skin is complex, and the sensitive skin mainly comprises the combined action of various factors such as endogenous susceptibility factors and exogenous stimulus factors, such as climate change, air pollution and the complexity of the types and components of cosmetics, which can increase the possibility of the sensitive skin appearing and receiving the stimulus. The mechanism of development of sensitive muscle is not well defined and may be associated with impaired skin barrier function, increased nerve conduction function and enhanced immune reactivity. After the barrier function of the skin is damaged, the insufficiently protected nerve endings are stimulated by the outside, and the transient potential receptor vanilloid subfamily member 1(TRPV1) distributed in the nociceptive sensory nerve endings, keratinocytes and mast cells is activated, so that the nerve conduction function is enhanced, itching, pain and burning sensation appear, and the keratinocytes and the mast cells are promoted to release inflammatory factors and chemokines, so that local vasodilatation and local inflammatory response are caused.
Proper use of care products is highly desirable for people with sensitive muscles. Developers in the cosmetics industry have become aware of this phenomenon and have placed increasingly important products on sensitive skin to develop active anti-sensitivity ingredients for various reasons and manifestations of sensitive skin. At present, a plurality of brands of products developed aiming at sensitive skin are sold in the market, some plant extracts with anti-sensitivity and anti-inflammation functions are added for nursing the sensitive skin so as to reduce the irritation of the products to the skin, but the plant extracts can not show the effect of the plant, the effective components of the plant raw materials are often complex, the expected effect can not be achieved after all the plant extracts are added, and even the situation that the effects are mutually inhibited can be caused, so that the effect of repairing the sensitive skin is not good.
Disclosure of Invention
Aiming at the technical problems, the invention provides the composition with the effects of moisturizing and soothing the skin and the application thereof, and the composition can effectively inhibit sensitive inflammatory reaction, quickly relieve red, itchy, dry and painful discomfort symptoms of sensitive muscles, consolidate skin barriers, immediately replenish and lock water for the skin, and moisturize and moisten the skin.
Therefore, the first technical scheme provided by the invention is as follows:
a composition with skin moisturizing and soothing effects comprises the following components: comprises the following components: 0.5-15 parts of eucommia ulmoides extract, 0.1-20 parts of rhodiola rosea extract, 1-20 parts of red cyst algae extract and 1.5-25 parts of madecassoside.
As a preferable technical scheme, the paint comprises the following components in parts by weight: 1-15 parts of eucommia ulmoides extract, 0.2-20 parts of rhodiola rosea extract, 2-20 parts of rhodospora polyspora extract, 3-25 parts of madecassoside, 5-30 parts of polyhydric alcohol and 5-25 parts of water.
As a preferable technical scheme, the paint comprises the following components in parts by weight: 3-7 parts of eucommia ulmoides extract, 2-8 parts of rhodiola rosea extract, 5-10 parts of red cyst algae extract, 5-17 parts of madecassoside, 10-25 parts of polyhydric alcohol and 10-20 parts of water.
As a preferable technical scheme, the mass ratio of the eucommia ulmoides extract to the rhodiola rosea extract to the haematococcus polyspora extract to the madecassoside is 1 (0.8-1.2) to 0.4-0.6 to 3-4.
As a preferable technical scheme, the hop extract powder also comprises 1 to 15 parts by weight of hop extract.
As a preferable technical scheme, the disinfectant also comprises 0.001 to 1 part of acetylated sodium hyaluronate by weight part.
As a preferable technical scheme, the lactobacillus/soybean milk fermentation product filter liquor also comprises 2 to 12 parts by weight of lactobacillus/soybean milk fermentation product filter liquor.
As a preferable technical scheme, the polyalcohol is one or more of glycerol, ethanol, butanediol, propylene glycol and 1-2-hexanediol.
The invention also provides another technical scheme:
the composition with the skin moisturizing and soothing effects is applied to the preparation of cosmetics, and the weight ratio of the composition with the skin moisturizing and soothing effects to the cosmetics is 0.1-15%.
As a preferable technical scheme, the weight ratio of the composition with the effects of moisturizing and soothing the skin in the cosmetic is 0.5-15%.
As a preferable technical scheme, the cosmetic comprises at least one of water, emulsion, cream, essence, gel and facial mask.
Compared with the prior art, the invention has the following beneficial effects:
the composition with the effects of moisturizing and soothing the skin provided by the invention can obviously reduce the skin redness symptom, improve the water content of the skin stratum corneum and has an obvious soothing and moisturizing effect on sensitive muscles. The eucommia ulmoides extract, the rhodiola rosea extract, the phaeocystis rosea extract and the madecassoside which are active components of four core plants in the composition are obtained by scientific formula screening, repeated tests and proportioning adjustment, and the active components play stronger anti-allergy and relieving effects through synergistic action. Wherein the eucommia ulmoides extract can reduce the expression of a key molecule PGE2 for regulating body temperature, reduce the temperature and fade red; the rhodiola rosea extract can inhibit the generation of substance P and histamine, relieve pain, pruritus and other discomforts; the red cyst algae extract can effectively reduce the expression of TRPV1 and reduce the skin neurogenic inflammation; the madecassoside has potent active ingredient, and has antipruritic, anti-erythema and desquamation improving effects. Furthermore, the invention also provides a composition containing the hop extract, wherein the hop is also called hop, can activate plants of skin 'bitter taste receptors', can trigger gustatory nerve excitation by activating sensory bitter taste receptors T2Rs in the skin, further leads the calcium ion concentration in cytoplasm to be increased, and causes the gene expression of intracellular metabolic pathways and skin immune systems, thereby enhancing the biological, chemical, physical and immune protective barriers of the skin. The acetylated sodium hyaluronate has good penetrating and absorbing capacity, can penetrate deeper skin layers, realizes quick water replenishing, quickly fills lost or damaged extracellular matrix, makes the skin plump and reduces fine wrinkles. The composition prepared by scientifically compounding the components is mild and safe, can quickly replenish water, moisturize and lock water, relieves the problems of red, swollen, itchy, painful and dry sensitive muscles and the like, and improves the skin barrier function.
Detailed Description
The technical solutions in the embodiments of the present invention are clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. For process parameters or conditions not specifically mentioned, it can be carried out with reference to conventional techniques.
The raw materials used in the invention are all obtained by a self-made mode or purchased from commercial channels.
Example 1
A composition with the effects of moisturizing and relieving skin comprises the following components: 5 g of eucommia ulmoides extract, 0.1 g of rhodiola rosea extract, 3 g of haematospora extract, 7 g of madecassoside, 10 g of butanediol and 15 g of water.
Example 2
A composition with the effects of moisturizing and relieving skin comprises the following components: 15 g of eucommia ulmoides extract, 10 g of rhodiola rosea extract, 20 g of haematospora extract, 25 g of madecassoside, 30 g of butanediol and 25 g of water.
Example 3
A composition with the effects of moisturizing and relieving skin comprises the following components: 4 g of eucommia bark extract, 4 g of rhodiola root extract, 6 g of red cyst algae extract, 15 g of madecassoside, 20 g of butanediol and 18 g of water.
Example 4
A composition with the effects of moisturizing and relieving skin comprises the following components: 4 g of eucommia bark extract, 4 g of rhodiola rosea extract, 6 g of red cyst algae extract, 15 g of madecassoside, 6 g of hop extract, 16 g of butanediol and 16 g of water.
Example 5
A composition with the effects of moisturizing and relieving skin comprises the following components: 4 g of eucommia bark extract, 4 g of rhodiola root extract, 6 g of red cyst algae extract, 15 g of madecassoside, 0.05 g of acetylated sodium hyaluronate, 20 g of butanediol and 18 g of water.
Example 6
A composition with the effects of moisturizing and relieving skin comprises the following components: 4 g of eucommia ulmoides extract, 4 g of rhodiola rosea extract, 6 g of rhodosporidium extract, 15 g of madecassoside, 5 g of lactobacillus/soybean milk fermentation product filtrate, 18 g of butanediol and 15 g of water.
Example 7
A composition with the effects of moisturizing and relieving skin comprises the following components: 4 g of eucommia bark extract, 4 g of rhodiola rosea extract, 6 g of red cyst algae extract, 15 g of madecassoside, 4 g of hop extract, 0.1 g of acetylated sodium hyaluronate, 17 g of butanediol and 17 g of water.
Example 8
A composition with the effects of moisturizing and relieving skin comprises the following components: 4 g of eucommia ulmoides extract, 4 g of rhodiola rosea extract, 6 g of red cyst algae extract, 15 g of madecassoside, 5 g of hop extract, 3 g of lactobacillus/soybean milk fermentation product filtrate, 15 g of butanediol and 15 g of water.
Example 9
A composition with the effects of moisturizing and relieving skin comprises the following components: 4 g of eucommia ulmoides extract, 4 g of rhodiola rosea extract, 6 g of rhodosporidium extract, 15 g of madecassoside, 0.05 g of acetylated sodium hyaluronate, 7 g of lactobacillus/soybean milk fermentation product filtrate, 16 g of butanediol and 15 g of water.
Example 10
A composition with the effects of moisturizing and relieving skin comprises the following components: 4 g of eucommia ulmoides extract, 4 g of rhodiola rosea extract, 6 g of rhodosporidium extract, 15 g of madecassoside, 5 g of hop extract, 0.05 g of acetylated sodium hyaluronate, 6 g of lactobacillus/soybean milk fermentation product filtrate, 15 g of butanediol and 12 g of water.
Example 11
A composition with the effects of moisturizing and relieving skin comprises the following components: 4 g of eucommia ulmoides extract, 6 g of rhodiola rosea extract, 4 g of red cyst algae extract, 12 g of madecassoside, 5 g of hop extract, 0.1 g of acetylated sodium hyaluronate, 7 g of lactobacillus/soybean milk fermentation product filtrate, 16 g of butanediol and 13 g of water.
Comparative example 1
Compared with example 3, the eucommia ulmoides extract is not contained, and the other components and contents are the same.
Comparative example 2
Compared with example 3, the rhodiola rosea extract is not contained, and the other components and contents are the same.
Comparative example 3
Compared with example 3, the product does not contain the red cyst algae extract, and the other components and contents are the same.
Comparative example 4
Compared with the example 3, the compound does not contain the madecassoside, and the other components and the content are the same.
The composition with the effects of moisturizing and relieving skin is added into cosmetics, and can be prepared into skin care cosmetics such as astringent, emulsion, cream, essence, facial mask, gel and the like according to the conventional process and auxiliary materials for preparing the cosmetics. The selection of the other ingredients in the cosmetic product at the time of manufacture may be made according to conventional procedures in the art.
In order to better illustrate the beneficial effects of the present invention, the following is a verification test of the technical solution provided by the present invention:
safety test of human body patch
45 volunteers aged 30-50 years were selected and 20. mu.g of each of the compositions of examples 1-11 and comparative examples 1-4 was taken into a qualified plaque tester. The patch containing the test sample was applied to the curved side of the forearm of the subject with a non-irritating tape and gently pressed with the palm to apply evenly on the skin for 24 h. The patch was removed 24h later and the skin reaction was observed at 0.5h, 24h, 48h after patch removal. The results show that the compositions of examples 1-11 and comparative examples 1-4 both show negative reactions. The test sample is deemed not to cause adverse reactions to the skin of the subject batch as specified in the technical specifications for cosmetic safety (2015 edition), and the composition of the present application has better safety in use.
Second, efficacy test
Test A: test for moisture retention
1. Skin moisture test
(1) Test samples: the test samples prepared by adding the compositions of examples 1 to 11 and comparative examples 1 to 4 to a general mask base, wherein the composition having the moisturizing and skin soothing effects accounts for 2% of the total mass of the mask, and the general mask base was used as a control group.
(2) The test method comprises the following steps: sensitive muscle subjects were screened by lactate sting for 60, and each group of samples for 5. After cleaning the face of the volunteer, a proper amount of the product is applied to the left half face and is evenly spread for 15 minutes, and then the volunteer is cleaned by clear water. The moisture content of the facial skin before and after the application of the sample was measured using a skin moisture content tester MDD4-corneometer cm825, respectively, and repeated 3 times to obtain an average value, thereby calculating the skin moisture content increase rate. The test site is prohibited from using the formulation that improves the efficacy test and is administered by drops, injection, orally, or in other forms. The test results are shown in Table 1.
Table 1 skin moisture test results
As can be seen from the experimental results in Table 1, the skin moisture content can be obviously increased by using the facial mask of the embodiment, particularly, the skin moisture content increase rate of the embodiment 10 and the embodiment 11 can reach 75% -80%, which is far higher than that of the comparative example, which shows that the composition of the invention can immediately replenish water and moisturize, while the sample of the comparative example has poor effect, which shows that the components of the composition of the invention can synergistically provide sufficient moisture for the skin, rapidly increase the moisture content of the horny layer of the skin and achieve better moisturizing effect.
2. Skin Water Dispersion loss test
The skin water loss TEWL value reflects the effect of improving skin barrier function, with lower TEWL values indicating less water loss and better skin barrier function.
(1) Test samples: the test samples prepared by adding the compositions of examples 1 to 11 and comparative examples 1 to 4 to a general mask base contained a composition having the moisturizing and skin soothing effects in an amount of 2% by mass of the total mass of the mask.
(2) The test method comprises the following steps: sensitive muscle subjects were screened by lactate sting for 40, and each group of samples for 5. After cleaning the face of the volunteer, a proper amount of the product is applied to the left half face and is evenly spread for 15 minutes, and then the volunteer is cleaned by clear water. The amount of loss of skin moisture after 1 hour and 6 hours of facial mask application was measured using a skin moisture loss meter TM300, and repeated 3 times, respectively, and the average value was calculated. The change of water loss is reflected in the test period, and the change rule of water loss in the test area along with time. The smaller the value, the less water loss and the stronger the skin barrier function; conversely, the weaker the skin barrier function. The change rate (water loss after use-initial water loss)/initial water loss, the smaller this value, the smaller the water loss, the stronger the skin barrier function of the test sample, and the better the moisturizing effect. The test site is prohibited from using the formulation that improves the efficacy test and is administered by drops, injection, orally, or in other forms. The test results are shown in Table 2.
TABLE 2 skin Water Dispersion loss TEWL values
The results in tables 1 and 2 show that the facial mask prepared from the composition of the embodiment of the invention has good moisturizing performance, and can significantly improve the skin barrier function and reduce the water dispersion loss of the skin. Particularly, after the facial mask added with the composition in example 11 is used, the moisture content of the facial mask is obviously higher than that of the compositions in examples 1, 3, 5, 7 and 9, which shows that the composition can lock moisture and reduce the loss rate of the moisture, and the humulus lupulus extract, sodium hyaluronate acetylated and lactobacillus/soybean milk fermentation product filtrate can further enhance the moisturizing performance of the composition, and confirms that the components of the composition can synergistically enhance the moisturizing effect.
And (3) testing B: test for soothing efficacy
(1) Test samples: the test samples prepared by adding the compositions of examples 1 to 11 and comparative examples 1 to 4 to a general mask base contained a composition having the moisturizing and skin soothing effects in an amount of 2% by mass of the total mass of the mask.
(2) The test method comprises the following steps: sensitive muscle subjects were screened by lactate sting for 60, with 4 subjects per group of samples. After cleaning the face of the volunteer, a proper amount of the product is applied to the left half face and is evenly spread for 15 minutes, and then the volunteer is cleaned by clear water. The average value of the redness of the skin is used for judging the efficacy of the sample on relieving and anti-allergy according to the disappearance of the red and itchy face of the subject. The average skin redness before and after using the test product described above is recorded. The test site is prohibited from using the formulation that improves the efficacy test and is administered by drops, injection, orally, or in other forms. The test results are shown in Table 3.
TABLE 3 average skin redness
| Sample (I) | L0 | L15min | △L |
| Example 1 facial mask | 33.2 | 31.3 | -1.9 |
| Example 2 face mask | 20.7 | 18.6 | -2.1 |
| Example 3 facial mask | 26.2 | 24.1 | -2.1 |
| Example 4 facial mask | 29.6 | 27.1 | -2.5 |
| Example 5 facial mask | 31.6 | 29.3 | -2.3 |
| EXAMPLE 6 facial mask | 27 | 24.9 | -2.1 |
| Example 7 facial mask | 29 | 26 | -3 |
| Example 8 facial mask | 25.6 | 22.9 | -2.7 |
| Example 9 facial mask | 28.9 | 26.3 | -2.6 |
| EXAMPLE 10 facial mask | 26 | 21.2 | -4.8 |
| EXAMPLE 11 facial mask | 30.9 | 26.7 | -4.2 |
| Comparative example 1 mask | 28.6 | 27.6 | -1.0 |
| Comparative example 2 mask | 21.8 | 20.9 | -0.9 |
| Comparative example 3 mask | 24.6 | 24.1 | -0.5 |
| Comparative example 4 mask | 34.6 | 34.1 | -0.5 |
As can be seen from the results of testing the average change of the skin redness in table 3 above, the average value of the skin redness of the subject was significantly reduced after using the mask sample prepared in the examples provided by the present invention, and it was observed that the red and itchy feeling of the subject was significantly improved, as compared with the mask sample using the comparative example. Therefore, the composition with the skin moisturizing and relieving effects can relieve the skin, and has a remarkable effect on the problems of skin pruritus, red swelling and the like.
In conclusion, the eucommia ulmoides extract, the rhodiola rosea extract, the rhodosporidium roseum extract and the madecassoside are scientifically matched, so that the synergistic effect is achieved, the moisturizing and moisturizing performance is remarkable, the moisture content of skin can be stably locked, the self-moisturizing function of cells is enhanced, the moisture content of stratum corneum cells is effectively improved, the barrier function of skin is effectively improved, the moisture loss is prevented, the stimulation of skin is reduced, and the symptoms of redness, swelling, itching, pain, dryness and the like of sensitive muscles are relieved. The hop extract, the acetylated sodium hyaluronate and the lactobacillus/soybean milk fermentation product filtrate are further compounded, so that the soothing and moisturizing effects of the composition are further enhanced.
The above embodiments are preferred embodiments of the present invention, but the present invention is not limited to the above embodiments, and any other changes, modifications, substitutions, combinations, and simplifications which do not depart from the spirit and principle of the present invention should be construed as equivalents thereof, and all such changes, modifications, substitutions, combinations, and simplifications are intended to be included in the scope of the present invention.
Claims (10)
1. The composition with the effects of moisturizing and soothing the skin is characterized by comprising the following components: 0.5-15 parts of eucommia ulmoides extract, 0.1-20 parts of rhodiola rosea extract, 1-20 parts of red cyst algae extract and 1.5-25 parts of madecassoside.
2. The composition with the effects of moisturizing and soothing skin according to claim 1, which is characterized by comprising the following components in parts by weight: 1-15 parts of eucommia ulmoides extract, 0.2-20 parts of rhodiola rosea extract, 2-20 parts of rhodospora polyspora extract, 3-25 parts of madecassoside, 5-30 parts of polyhydric alcohol and 5-25 parts of water.
3. The composition with the effects of moisturizing and soothing skin according to claim 2, which is characterized by comprising the following components in parts by weight: 3-7 parts of eucommia ulmoides extract, 2-8 parts of rhodiola rosea extract, 5-10 parts of red cyst algae extract, 5-17 parts of madecassoside, 10-25 parts of polyhydric alcohol and 10-20 parts of water.
4. The composition with the effects of moisturizing and soothing skin as claimed in claim 3, wherein the mass ratio of the eucommia ulmoides extract to the rhodiola rosea extract to the haematospora extract to the madecassoside is 1 (0.8-1.2) to 0.4-0.6 to 3-4.
5. The composition with the effects of moisturizing and soothing skin according to any one of claims 1 to 4, wherein the composition further comprises 1 to 15 parts by weight of a hop extract.
6. The composition with the effects of moisturizing and soothing skin according to claim 5, further comprising 0.001-1 part by weight of acetylated sodium hyaluronate.
7. The composition with the effects of moisturizing and soothing skin according to claim 6, further comprising 2-12 parts by weight of lactobacillus/soybean milk fermentation product filtrate.
8. Use of the composition with skin moisturizing and soothing effects of any one of claims 1 to 7 in cosmetics, wherein the composition with skin moisturizing and soothing effects is present in an amount of 0.1 to 15% by weight of the cosmetic.
9. The use of claim 8, wherein the composition having skin moisturizing and soothing effects is present in the cosmetic in an amount of 0.5% to 15% by weight.
10. The use of claim 8, wherein the cosmetic comprises at least one of water, lotion, cream, essence, gel, and mask.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111059569.1A CN113908089A (en) | 2021-09-10 | 2021-09-10 | Composition with effects of moisturizing and soothing skin and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111059569.1A CN113908089A (en) | 2021-09-10 | 2021-09-10 | Composition with effects of moisturizing and soothing skin and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113908089A true CN113908089A (en) | 2022-01-11 |
Family
ID=79234387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111059569.1A Pending CN113908089A (en) | 2021-09-10 | 2021-09-10 | Composition with effects of moisturizing and soothing skin and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113908089A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105267123A (en) * | 2015-11-18 | 2016-01-27 | 陈洁娣 | Whitening and hydrating toner and method for manufacturing same |
| KR101727537B1 (en) * | 2016-12-28 | 2017-05-02 | 이경화학 주식회사 | Manufacturing method of herb cosmetic composition for skin moisturizing and soothing and cosmetic composition obtained thereby |
| CN111588687A (en) * | 2020-07-07 | 2020-08-28 | 上海新高姿化妆品有限公司 | Water-oil bin-separated moisturizing and relieving composition, preparation method and application |
-
2021
- 2021-09-10 CN CN202111059569.1A patent/CN113908089A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105267123A (en) * | 2015-11-18 | 2016-01-27 | 陈洁娣 | Whitening and hydrating toner and method for manufacturing same |
| KR101727537B1 (en) * | 2016-12-28 | 2017-05-02 | 이경화학 주식회사 | Manufacturing method of herb cosmetic composition for skin moisturizing and soothing and cosmetic composition obtained thereby |
| CN111588687A (en) * | 2020-07-07 | 2020-08-28 | 上海新高姿化妆品有限公司 | Water-oil bin-separated moisturizing and relieving composition, preparation method and application |
Non-Patent Citations (1)
| Title |
|---|
| 张堃等: "透明质酸的结构、性能、改性和应用研究进展" * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10980851B2 (en) | Topical skincare compositions comprising Centella asiatica selected triterpenes | |
| CN109288764B (en) | Hydrolat spray and preparation method thereof | |
| WO2018082116A1 (en) | External traditional chinese medicine composition and skin care preparation having effect of whitening and freckle-removing | |
| CN106236690A (en) | A kind of amino acid cleansing cream containing various plants composition | |
| CN113041172B (en) | Sebum membrane bionic composition for skin barrier repair, application thereof and cosmetics | |
| CN103976906A (en) | Plant extract mixture having moisturizing and inflammation-diminishing effects | |
| WO2024045952A1 (en) | Recombinant collagen-containing composition having effects of repairing and soothing, eye cream containing same, preparation method therefor, and use thereof | |
| CN110101591B (en) | Long-acting moisturizing composition and preparation method and application thereof | |
| CN105998617B (en) | External traditional Chinese medicine extract with effect of relieving senile skin itch and preparation method and application thereof | |
| KR101114161B1 (en) | Body Detergent composition for moisturizing or soothing the skin containing Aloe barbadensis miller extract and Althaea officinalis root extract | |
| CN111053728A (en) | Composition for regulating water-oil balance of skin and cosmetic thereof | |
| CN114344231A (en) | Saffron allergy-relieving composition and application thereof | |
| CN112370408A (en) | Composition with high-power moisturizing effect and application of composition in cosmetics | |
| CN116617106A (en) | Protopanaxatriol saponin allergy-relieving repairing composition, and preparation method and application thereof | |
| KR20100005481A (en) | Composition for improving scalp and hair condition | |
| CN113908089A (en) | Composition with effects of moisturizing and soothing skin and application thereof | |
| CN115670993A (en) | Preparation method and application of supramolecular composition with repairing and relieving effects | |
| AU2020100737A4 (en) | Composition for removing striae atrophicae | |
| CN113499271A (en) | Anti-allergy compound and preparation method and application thereof | |
| CN113143788A (en) | Multi-effect composition and face cream with moisturizing, repairing and relieving functions | |
| CN112807238A (en) | Anti-inflammatory and soothing repair gel for skin and preparation method thereof | |
| CN116570542B (en) | Composition with effects of relaxing, relieving, resisting and relieving itching and application thereof | |
| CN116370522B (en) | Composition for reducing local cellulite, carrier emulsion and preparation method | |
| Hasibuan et al. | Formulation and Evaluation of Body Scrub Cream Containing Ethanol Extract of Black Cumin Seeds (Nigella sativa L.) and Coffee Grounds (Coffea arabica L.) as Anti-aging | |
| CN115813831B (en) | Composition with anti-allergy relieving effect and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220111 |
|
| RJ01 | Rejection of invention patent application after publication |